Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

HempAmericana CEO Issues Letter on Shift to Commercial-Stage Operations


Posted on: 10 Sep 18

NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE) -- HempAmericana, Inc.(GlobeNewsWire)—via OTC PR WIRE-- (OTC:HMPQ) (“HempAmericana” or the “Company”) CEO issues the following letter to Shareholders:

Dear Valued Shareholder,

Last week, we put out a press release that represented, for myself and my team, truly the most exciting moment in the history of HempAmericana – exciting because of all the hurdles we have overcome during the past year, exciting because of the power and scale of the opportunity that lies in front of us, exciting because we have made it to the edge of commercial operations with such a tremendous set of ingredients in place in terms of balance sheet health, a top-tier team, and a best-in-class production facility.

It has been a long and arduous road, but we are finally now an active producer of cannabidiol (CBD), and have a number of sizeable purchase orders already in the books and already being filled.

For a little background, our first zero-waste extraction and production facility – located in Augusta, Maine – has been constructed from the ground up to give HempAmericana a genuine marketplace advantage. We have installed and engaged market-leading technology designed to maximize the purity and potency of extracted cannabidiol, including a Vitalis RL-245 high-capacity supercritical CO2 CBD Oil extraction machine, a Gilson CPC 1000 centrifugal partition chromatography separator system, and a PLC 2500 HPLC+UV Detector system.

This equipment, together, represents a next-generation extraction and processing system capable of producing 99% pure CBD Oil concentrate in scalable quantities.

In other words, right now at HempAmericana, we just “switched on” one of the most advanced high-capacity CBD Oil extraction and production facilities in the Eastern US market. And we have begun to process our initial stock of 4,000 lbs of premium-grade hemp flower.

As we begin to fully-engage commercial stage operations, we will have a number of very exciting new announcements to come.

Also, we will be expanding the HempAmericana brand and organization into other hemp-related ventures. And we look forward to discussing those plans in greater detail in upcoming communications.

In addition, as we have previously discussed, our Augusta facility has been established as a pilot program to serve as the basis for establishing several other zero-waste CBD extraction and production facilities as soon as this initial facility has been producing at full-scale for its initial period with a stable team and optimal results in place. We look forward to beginning work on our next site very soon, and our shareholders can expect updates on this process shortly.

Finally, HempAmericana, along with its legal counsel, has been working actively and diligently with the OTC Markets Group (the “OTC”) toward the removal of the Caveat Emptor designation at OTCmarkets.com. The team at the OTC continues to be very helpful, and we have complied with all of their requests. Recently, we received a request for additional information, which we promptly supplied, and it is now our understanding that this represented the final step toward resolving this matter.

Most importantly, in closing, to our dedicated and supportive shareholders I would like to say the following: We couldn’t have made it here without you, and we have our most exciting days just ahead of us!


Best Regards,
Salvador Rosillo

About HempAmericana, Inc.
HempAmericana is currently in the rolling paper and CBD oil business using the brand name Weed Got Oil. Search Rolling Thunders hemp papers on YouTube for a product demonstration of the Company's papers. The company owns an extraction machine and now plans to become a leader in the CBD oil market by establishing three laboratories for the extraction and research of the oils contained in the hemp plant. HempAmericana also researches, develops and sells products made of industrial hemp. See more at http://www.HempAmericana.net.

Safe Harbor Provision Cautionary statement for purposes of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995: Information in this news release contains forward-looking statements that involve risks, uncertainties and assumptions. If such risks or uncertainties materialize or such assumptions prove incorrect, the results of the Company and its consolidated subsidiaries could differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks, uncertainties and assumptions include the execution and performance of contracts by the Company and its customers, suppliers and partners. Please also review Hemp Americana annual and quarterly financials for a more complete discussion of risk factors. The Company disclaims any obligation to update or revise statements contained in this news release based on new information or otherwise. This communication shall not constitute an offer to sell or the solicitation of an offer to buy securities nor shall there be any sale of these securities in any state in which such solicitation or sale would be unlawful prior to registration or qualification of these securities under the laws of any such state.

Contact:
HempAmericana.net
Salvador Rosillo

GlobeNewswire
globenewswire.com

Last updated on: 10/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.